SCHEMBL2310086

SCHEMBL2310086

OCCc1cccc2ccc3c4ccccc4ccc3c12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.50
ALDH1A1 P00352 2/20 0.50
HSD17B10 Q99714 2/20 0.50
THRB P10828 1/20 0.50
HPGD P15428 1/20 0.50
HPRT1 P00492 3/20 0.48
ERBB2 P04626 1/20 0.46
FYN P06241 1/20 0.46
MAOA P21397 1/20 0.46
ACHE P22303 1/20 0.46
AHR P35869 1/20 0.46
TDP1 Q9NUW8 2/20 0.41
CYP2A6 P11509 1/20 0.41
TSHR P16473 1/20 0.41
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ACP3 P15309 1/20 0.39
HSP90AA1 P07900 1/20 0.38
HNF4A P41235 1/20 0.38
MTNR1A P48039 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2311141 0.91 CYP1A2 (0.47) CYP1A2ALDH1A1HSD17B10THRBHPGD
SCHEMBL2310354 0.91 CYP1A2 (0.43) CYP1A2ALDH1A1HSD17B10THRBHPGD
SCHEMBL2310469 0.89 CYP1A2 (0.43) CYP1A2ALDH1A1HSD17B10THRBHPGD
SCHEMBL2310479 0.89 HPRT1 (0.44) CYP1A2ALDH1A1HSD17B10THRBHPGD
SCHEMBL2312926 0.87 HPRT1 (0.54) CYP1A2ALDH1A1HSD17B10HPRT1TDP1
SCHEMBL2312666 0.87 HPRT1 (0.54) CYP1A2ALDH1A1HSD17B10HPRT1TDP1
SCHEMBL2310531 0.87 CYP1A2 (0.42) CYP1A2ALDH1A1HSD17B10THRBHPGD
SCHEMBL2310818 0.86 HPRT1 (0.48) CYP1A2ALDH1A1HSD17B10THRBHPGD
SCHEMBL2308434 0.85 CYP1A2 (0.42) CYP1A2ALDH1A1HSD17B10THRBHPGD
SCHEMBL2309146 0.85 CYP1A2 (0.50) CYP1A2ALDH1A1HSD17B10THRBHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989517-B2 Actinic ray curable composition, actinic ray curable ink, and image formation process employing the same KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2011-08-02 US disclosed
US-20070123600-A1 ACTINIC RAY CURABLE COMPOSITION, ACTINIC RAY CURABLE INK, AND IMAGE FORMATION PROCESS EMPLOYING THE SAME KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-05-31 US disclosed